AAAAAA

   
Results: 1-7 |
Results: 7
Impact of abciximab and coronary stenting on outcomes and costs of percutaneous coronary interventions in a community hospital
Authors: Lucore, CL Trask, RV Mishkel, GJ Rocha-Singh, KJ Shelton, ME Mikell, FL Ligon, RW
Citation: Cl. Lucore et al., Impact of abciximab and coronary stenting on outcomes and costs of percutaneous coronary interventions in a community hospital, CORON ART D, 12(2), 2001, pp. 135-142
Comparative 30-day economic and clinical outcomes of platelet glycoproteinIIb/IIIa inhibitor use during elective percutaneous coronary intervention:Prairie ReoPro Versus Integrilin Cost Evaluation (PRICE) Trial
Authors: Lam, W Gill, JB Trask, RV Mallavarapu, CT Rocha-Singh, KJ Mikell, FL Mishkel, GJ Mayer, SA Aguirre, FV Yakel, D Steen, MS Kacich, RL Shelton, ME Chaitman, BR Stocke, K Katholi, R Pianfetti, L Tatum, M McMillan, S Ligon, RW Holloway, C Cohen, DJ Staten, N Laswell, K Sullivan, P Rothert, T Page, L Brooks, M Entwistle, K Drew, D
Citation: W. Lam et al., Comparative 30-day economic and clinical outcomes of platelet glycoproteinIIb/IIIa inhibitor use during elective percutaneous coronary intervention:Prairie ReoPro Versus Integrilin Cost Evaluation (PRICE) Trial, AM HEART J, 141(3), 2001, pp. 402-409
Ad hoc coronary intervention
Authors: Blankenship, JC Mishkel, GJ Chambers, CE Hodgson, JM Holmes, DR Sheldon, W Schweiger, MJ Cowley, MJ Popma, JJ
Citation: Jc. Blankenship et al., Ad hoc coronary intervention, CATHET C IN, 49(2), 2000, pp. 130-134
Clinical predictors of improved long-term blood pressure control after successful stenting of hypertensive patients with obstructive renal artery atherosclerosis
Authors: Rocha-Singh, KJ Mishkel, GJ Katholi, RE Ligon, RA Armbruster, JA McShane, KJ Zeck, KJ
Citation: Kj. Rocha-singh et al., Clinical predictors of improved long-term blood pressure control after successful stenting of hypertensive patients with obstructive renal artery atherosclerosis, CATHET C IN, 47(2), 1999, pp. 167-172
Economic implications of coronary stenting with adjunctive IIb/IIIa receptor antagonists in a community hospital
Authors: Lucore, CL Mishkel, GJ Ligon, RW Rocha-Singh, K
Citation: Cl. Lucore et al., Economic implications of coronary stenting with adjunctive IIb/IIIa receptor antagonists in a community hospital, J INVAS CAR, 11, 1999, pp. 14C-20C
Outpatient stenting using the femoral approach with vascular sealing (Reprinted from American Journal of Cardiology, vol 82, pg 35S, 1998)
Authors: Wilentz, JR Mishkel, GJ Reimers, CD Fox, J Ravi, K Sherman, W McDermott, D Kupersmith, A
Citation: Jr. Wilentz et al., Outpatient stenting using the femoral approach with vascular sealing (Reprinted from American Journal of Cardiology, vol 82, pg 35S, 1998), J INVAS CAR, 11, 1999, pp. 5B-5B
Clopidogrel as adjunctive antiplatelet therapy during coronary stenting
Authors: Mishkel, GJ Aguirre, FV Ligon, RW Rocha-Singh, KJ Lucore, CL
Citation: Gj. Mishkel et al., Clopidogrel as adjunctive antiplatelet therapy during coronary stenting, J AM COL C, 34(7), 1999, pp. 1884-1890
Risultati: 1-7 |